Patients

5 Keys to Success in the New Patient Economy

5 Keys to Success in the New Patient Economy

In the webinar, 5 Keys to Success in the New Patient Economy, you'll learn tips and strategies for transforming your patient engagement model.

What pharma brands can learn from Lions Health

What pharma brands can learn from Lions Health

By

Drugmakers test out virtual reality, partner with companies like Spotify, and go for the cinematic at Cannes Lions.

The CIO, reimagined for pharma

The CIO, reimagined for pharma

By

Despite the increasing importance of the CIO post, top technology professionals still find it hard to break into the uppermost ranks at life-sciences companies.

Leadership Exchange: Engaging the Millennial Doctor

Leadership Exchange: Engaging the Millennial Doctor

By

In partnership with inVentiv Health, MM&M found a millennial doctor to ask about her frustrations with the existing pharma marketing model to her willingness to text patients.

From the Editor: The Patient Journey 2016

From the Editor: The Patient Journey 2016

By

The truth is, biopharma marketing and behavioral psychology have a lot in common. Ultimately, both aim to nudge people to make a medical or lifestyle change that could positively impact their health.

The Science and Psychology behind Patient Engagement

The Science and Psychology behind Patient Engagement

Where are the discussions about applying proven behavior change models or the principles of adult learning and health literacy?

4 trends with the potential to change behavior in the patient journey

4 trends with the potential to change behavior in the patient journey

By

It's a common refrain in healthcare and among patients, providers, and payers: Despite massive investment, no one has figured out how to change human behavior.

The Marketer's Role is To Be the Voice of the Patient

The Marketer's Role is To Be the Voice of the Patient

Maybe we have just forgotten the true reason why marketing exists in organizations.

An emotional bond with patients is key, says Elemental Machines' Iyengar

An emotional bond with patients is key, says Elemental Machines' Iyengar

By

At the MM&M Transforming Healthcare conference, Iyengar told attendees how to take into account a consumer's behavior and emotion when marketing medical products.

Is virtual reality the ultimate emotive storytelling tool?

Is virtual reality the ultimate emotive storytelling tool?

By

Wieden+Kennedy Portland's VR work for the National Multiple Sclerosis Society lets wheelchair-bound patients experience their favorite activities again, like dancing or surfing.

Infographic: Better promotion of clinical trials

Infographic: Better promotion of clinical trials

Companies spend $2 billion per year recruiting patients for clinical trials. A survey of 702 adults, conducted from December 2015 to January 2016, points to a need for more awareness.

Levy joins PatientsLikeMe, bringing the analyst closer to the patient in latest career move

Levy joins PatientsLikeMe, bringing the analyst closer to the patient in latest career move

By

Monique Levy, who's spent more than a decade helping drugmakers understand technology shifts, has joined PatientsLikeMe, the online discussion platform for people with chronic illness.

Balancing Opportunity and Responsibility in Healthcare Targeting

Balancing Opportunity and Responsibility in Healthcare Targeting

If you truly understand who your high writers and compliant patients are, you'll understand when and how to communicate with prospects that look and act like them.

No More 'Patient-Centric,' Please

No More 'Patient-Centric,' Please

By

Maybe it's time for pharma and healthcare marketers to put all the "patient-centric" talk on the shelf — not the actual paying-attention-to-patients part of it, but the trumpeting of it as the most noble of life-science virtues.

How My GI Health changed the conversation for patients

How My GI Health changed the conversation for patients

By

The motivating force behind My GI Health met initial resistance. After all, it came from a company executive who professed that his goal was to benefit all companies within that therapeutic area.

Ironwood's McCourt bets big on data and the patient-physician dialogue

Ironwood's McCourt bets big on data and the patient-physician dialogue

By

Tom McCourt says he's "a marketing guy who hopefully understands a little about drug development" even as he guided drugs like Prilosec to market.

The truth about a doctor's day: know-it-all patients and no time for lunch

The truth about a doctor's day: know-it-all patients and no time for lunch

By

There are big changes underway in the doctor-patient relationship, a study suggests, and it's a new reality to which biopharma must adjust.

Five things for pharma marketers to know: Tuesday, March 1, 2016

Five things for pharma marketers to know: Tuesday, March 1, 2016

By

Analysis questions Addyi's effectiveness; Horizon is subpoenaed about its patient assistance programs; AstraZeneca sells non-U.S. rights to constipation drug

My Orphan Drug Awakening

My Orphan Drug Awakening

One conversation with a real patient—followed by many more conversations with more patients—helped me see how important our work can be in the eyes of patients.

6 insights into today's healthcare consumer

6 insights into today's healthcare consumer

Finn Partners surveyed 1,000 adults to understand how often young Americans change doctors and how they talk to pharmacists.

What It Will Take to Make Pharma Consumer-Centric

What It Will Take to Make Pharma Consumer-Centric

If we as an industry want to be customer-centric in the same way that Apple or Amazon is, we need to change nearly everything about how we do business.

The New Patient Centricity Demands Clarity, Community—And Confidence

The New Patient Centricity Demands Clarity, Community—And Confidence

When it came to the issue of patient-centricity, each of us harbored at least a hint of cynicism.

Pricing debate changes perception of patient assistance programs

Pricing debate changes perception of patient assistance programs

By

Providing financial assistance to patients has become a common refrain in drugmakers' defense of high-priced drugs.

Is Pharma Taking the Wrong Approach to Patient-Centricity?

Is Pharma Taking the Wrong Approach to Patient-Centricity?

Life-sciences companies often behave as though focusing on patient needs is simply a matter of asking, "How can we provide patients with more services?

Is It Possible For Pharma To Be Truly Patient-centric?

Is It Possible For Pharma To Be Truly Patient-centric?

Although the industry wants to help patients get healthy - and wants to be a critical part in that process - there's a delicate balance to strike between selling product and achieving healthier outcomes.

Five things for pharma marketers to know: Wednesday, November 4, 2015

Five things for pharma marketers to know: Wednesday, November 4, 2015

By

Many patients allow doctors to access their social-media accounts; Turing will reportedly lower the price of Daraprim by 10%; WebMD reports boost in traffic

EHRs, Patient Portals, and the "Four P's"

EHRs, Patient Portals, and the "Four P's"

Patient portals are an underutilized resource for a population hungry for health information.

How To Fix The 'Problems' With Social Listening

How To Fix The 'Problems' With Social Listening

Work hard to get everyone in your company to understand what you can learn from social listening—you'll know you're successful when inquisitive minds throughout the company start asking you the question, "Can we find out what patients are saying about this brand online?"

Orchestrating Key Stakeholder Engagement for Launch Success

Orchestrating Key Stakeholder Engagement for Launch Success

The modern healthcare landscape is complicated, and the terrain is even more gnarled for life sciences companies trying to bring new products to market.

Five things for pharma marketers to know: Friday, July 17

Five things for pharma marketers to know: Friday, July 17

By

Gilead will limit financial assistance to patients to pressure payers; Biogen reports another PML case related to Tecfidera; Valeant buys Egyptian drugmaker

OPINION

Email Newsletters